Summit Financial’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Other funds holding DXCM
VCM
VPM
Summit Financial's DXCM Position: Q1 2026 in Review
Summit Financial increased its DexCom (DXCM) stake by 1.8% in Q1 2026, buying an estimated $5.01K and bringing the position to 4,076 shares worth $256K. The position accounts for ﹤0.01% of the portfolio, ranked #1257.
Summit Financial first reported a position in DXCM in Q1 2025 and has held it in 5 quarters since. The position peaked at $386K in Q2 2025. 957 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.
- Summit Financial held 4,076 shares of DexCom worth $256K as of Q1 2026.
- Summit Financial bought 72 DexCom shares in Q1 2026, an estimated $5.01K.
- DexCom made up ﹤0.01% of Summit Financial's portfolio in Q1 2026, its #1257 holding.
- Summit Financial first reported a position in DexCom in Q1 2025 and has held it in 5 quarters since.
- Summit Financial's DexCom position peaked at $386K in Q2 2025.
- 957 funds tracked by Wall St. Rank held DexCom as of Q1 2026.
Based on Summit Financial's 13F filing for Q1 2026, filed 15 May 2026.